Orlando
-
ObvioHealth to collect data for virtual Covid-19 registry study after app gets clearance
The company launched the study to collect data on Covid-19 symptoms and immune responses earlier this month. The goal is to recruit 10,000 participants and then follow them for six months. Participants developing symptoms will be eligible for serological testing.
-
HIMSS cancels over coronavirus concerns
HIMSS cancelled its annual conference for the first time in more than 50 years. Conference leaders said they made the decision after recent reports about COVID-19 from the WHO and CDC.
-
Do you advise self-insured employers? You Can Help Us!
Take part in this survey and share some of the trends you are seeing among your clients across healthcare, including chronic conditions, behavioral health and navigation.
-
Loxo drug shows activity in leukemia, lymphoma patients resistant to marketed therapies at ASH
Data showed LOXO-305 was broadly effective in patients resistant to BTK inhibitors regardless of whether they harbored a putative mechanism of resistance to the widely used blood cancer drugs.
-
DOJ throws support to Oscar Health in legal spat with Florida Blue
The Department of Justice has weighed in on Oscar Health’s side arguing that the antitrust concerns raised by the company in court should not be thrown out and backing Oscar’s claims of “coercion” in the implementation of Florida Blue’s exclusive broker policy.
-
7 takeaways from HIMSS 2019
From interoperability to AI to cybersecurity, here’s a roundup of some key insights from this year’s HIMSS conference in Orlando, Florida.
-
Events, Artificial Intelligence
AI is best leveraged when it’s tied to outcomes
“If we just talk about AI without tying that to better access globally, lower costs, … better outcomes for our patients at the end of the day — we’re not leveraging this transformational technology in the right way,” GE Healthcare’s Karley Yoder said during a panel discussion at HIMSS.
-
For these investors at HIMSS, their no. 1 investment pick for 2019 is…
At the Health 2.0 VentureConnect forum at HIMSS three investors described their no. 1 investment area of interest in 2019.
-
Mayo Clinic CIO in dealing with his own cancer “cringes” at state of IT usability
At the annual HIMSS conference in Orlando, Cris Ross, Mayo Clinic’s CIO, speaks passionately and powerfully about how his own cancer diagnosis has allowed him to see the challenges of health IT in a new light.
-
Superheroes kick off #HIMSS19
The superhero theme of the HIMSS opening reception — which featured an appearance from Superman and Wonder Woman — relates back to the larger conference theme: “Champions of Health Unite.”
-
Trayt Health Seeks to Increase Access to Diagnoses and Treatments
CEO Malekeh Amini explains how Trayt Health can bridge the gap for patients seeking neurological care.
-
Florida Blue gets legal win against Oscar Health in exclusive broker dispute
Last year, the New York-based company sued insurer Florida Blue, a licensee of the Blue Cross Blue Shield Association over its exclusive broker policy, which it claimed was anti-competitive and reduces customer choice.
-
Oscar Health sues Florida Blue to end exclusive broker policy
Oscar claims that the insurer’s practice of pressuring local brokers from selling other com is anti-competitive and reduces customer choice.
-
American Heart Association, Anthem unveil CPR training kiosks in airports
In an effort to educate travelers on the significance of cardiac arrest, the American Heart Association and Anthem Foundation are installing hands-only CPR training kiosks in three airports across the country.
-
AI is “still pretty dumb” and like a “2-year-old”
Mayo Clinic’s chief information officer describes the limitations of AI describing the nascent technology as a 2-year-old child learning to interact with the world.